ciclopirox has been researched along with Ewing Sarcoma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciclopirox (CPX) is a synthetic antifungal drug that is mainly used to treat dermatomycoses." | 5.48 | Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma. ( Ji, W; Li, J; Xia, H; Yuan, B, 2018) |
| "Ciclopirox (CPX) is a synthetic antifungal drug that is mainly used to treat dermatomycoses." | 1.48 | Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma. ( Ji, W; Li, J; Xia, H; Yuan, B, 2018) |
| "Ewing sarcoma is a highly aggressive bone and soft tissue cancer that is caused by the EWS-FLI1 fusion protein." | 1.43 | Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma. ( Gordon, DJ; Goss, KL, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuan, B | 1 |
| Ji, W | 1 |
| Xia, H | 1 |
| Li, J | 1 |
| Goss, KL | 1 |
| Gordon, DJ | 1 |
2 other studies available for ciclopirox and Ewing Sarcoma
| Article | Year |
|---|---|
Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.
Topics: Antifungal Agents; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Ciclopirox; Collagen Typ | 2018 |
Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Ciclopirox; Cl | 2016 |